ABSTRACT
Three-dimensional printed polymers offer unprecedented advantages for prosthetic applications, namely in terms of affordability and customisation. This work thus investigates the possibility of designing an additively manufactured prosthetic foot using continuous fibre-reinforced polymers as an alternative to composite laminate ones. A numerical approach was thus proposed and validated as a possible design tool for additively manufactured composite feet. This approach was based on explicit separate simulations of the infill, aiming to capture its homogenised engineering constants. The approach was validated on simple sandwich specimens with a different infill geometry: stiffness predictions were within the experimental standard deviation for 3D simulations. Such an approach was thus applied to redesign a laminated component of a foot prosthesis inspired by a commercial one with new additive technology. The new component was about 83% thicker than the reference one, with 1.6 mm of glass fibre skins out of about 22 mm of the total thickness. Its stiffness was within 5% of the reference laminated one. Overall, this work showed how additive manufacturing could be used as a low-cost alternative to manufacturing affordable prosthetic feet.
ABSTRACT
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and subsequently paralysis. It begins subtly with focal weakness but spreads relentlessly to involve most muscles, thus proving to be effectively incurable. Typically, death due to respiratory paralysis occurs in 3-5 years. To date, it has been shown that the management of ALS patients is best achieved with a multidisciplinary approach, and with the help of emerging technologies ranging from multidisciplinary teleconsults (for monitoring the dysphagia, respiratory function, and nutritional status) to brain-computer interfaces and eye tracking for alternative augmentative communication, until robotics, it may increase effectiveness. The COVID-19 pandemic created a spasmodic need to accelerate the development and implementation of such technologies in clinical practice, to improve the daily lives of both ALS patients and caregivers. However, despite the remarkable strides that have been made in the field, there are still issues to be addressed. This review will be discussed on the eureka moment of emerging technologies for ALS, used as a blueprint not only for neurodegenerative diseases, examining the current technologies already in place or being evaluated, highlighting the pros and cons for future clinical applications.